By Conor Hale | FierceBiotech | October 30, 2019
Sherlock Biosciences, maker of CRISPR-based field tests, is partnering up with Mologic to develop a suite of rapid and “instrument-free” molecular diagnostics that work without the need for electricity or temperature controls.
The …
By Ben Adams | FierceBiotech | October 30, 2019
As Amgen rides the wave of hype and hope for its early-stage KRAS effort as well as other cancer assets in its pipeline, this is pushing out its work on neuroscience.
To that …
By Ben Adams | FierceBiotech | October 29, 2019
Not a bad day’s work for Atlas-seeded startup Disc Medicine: It’s managed a healthy $50 million series A, led by Novo Nordisk’s VC arm, gained a new executive chair from Nimbus and nabbed …
Isma Benattia, MBA ’18 
Jane Levy, MBA ‘97 
Patrick Rivelli, SM ‘91 
Rick Ruvkun, MBA ’83 
David Segrera, MBA ’11 
Vin Sharma, MBA ’07 
